We value the opportunity to connect with patients, caregivers, healthcare professionals, researchers, employees, investors, and the broader community. Our goal on social media is to foster respectful, informative, and constructive dialogue while sharing updates about our science, mission, and progress.

Because we operate in a highly regulated industry, our engagement is guided by legal, ethical, and regulatory standards. These Community Guidelines outline expectations for participating in our online community.

1. Respectful and Relevant Engagement

We encourage thoughtful discussion related to Immusoft, our research, and the communities we serve. When engaging on our channels, please:

• Stay on topic and relevant to the content shared
• Treat others with respect and professionalism
• Engage in constructive, good-faith dialogue

We may remove content or limit engagement that is not aligned with these principles.

2. Content Moderation and Prohibited Content

To maintain a safe and compliant environment, we reserve the right to remove comments, restrict users, or report content that includes:

• False, misleading, or unsubstantiated claims
• Confidential, proprietary, or sensitive information
• Promotion of products or services, spam, or unauthorized advertising
• Comments about participation in ongoing clinical trials
• Medical or treatment claims (including about investigational therapies)
• Content that violates intellectual property rights
• Harassment, hate speech, threats, or offensive language
• Illegal activity or encouragement of unsafe behavior
• Malicious code, links, or cybersecurity risks
• Content that violates platform-specific terms of use

We may also limit engagement on topics where we are unable to respond due to regulatory requirements.

3. Medical and Scientific Information

Our social media channels are not intended for medical advice or treatment guidance.

• Please consult a qualified healthcare professional for medical questions
• We do not engage in discussions about specific treatment decisions or individual health situations
• We do not provide commentary on investigational therapies beyond publicly available information

4. Patient Safety and Adverse Event Reporting

Patient safety is a priority.

If you believe you have experienced a side effect or adverse event related to an Immusoft therapy or investigational product:

• Please contact your healthcare provider immediately
• You may report adverse events to the U.S. Food and Drug Administration via FDA MedWatch

We may follow up or remove posts containing potential safety information to comply with regulatory obligations.

5. Privacy and Personal Information

Please do not share personal, medical, or confidential information about yourself or others on our social channels.

Any information shared publicly may be visible to others and may be used by Immusoft to respond or comply with regulatory requirements.

6. Engagement and Response Expectations

We strive to monitor and engage with our community; however:

• We may not be able to respond to every comment or message
• Response times may vary
• Certain topics may not receive a response due to regulatory or business constraints

7. Use of User Content

By engaging with our social media channels (e.g., commenting, tagging, or messaging), you acknowledge that:

• Your public content may be visible to others
• We may engage with or reference your content (e.g., respond, reshare, or quote)

If you prefer not to have your content used in this way, please avoid tagging or interacting publicly with our accounts.

8. Third-Party Content and Links

Our channels may include or reference third-party content or accounts.

• Such references do not constitute endorsement
• We are not responsible for the accuracy or practices of third-party content

Similarly, accounts we follow, like, or engage with should not be interpreted as endorsements.

9. Platform Terms and Eligibility

Your use of our social media channels is also subject to the terms and conditions of each platform (e.g., LinkedIn, X, YouTube).

You must meet the minimum age and eligibility requirements of those platforms to participate.

10. Updates to These Guidelines

These Community Guidelines may be updated periodically. We encourage you to review them regularly.

11. Contact Information

For questions or inquiries, please contact info@immusoft.com.